Savara Announces Participation in Jefferies Global Healthcare Conference
The live webcast and subsequent replay will be available on the 'Events & Presentations' section of the Company's corporate website and will be archived for 90 days.
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, MOLBREEVI*, is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). MOLBREEVI is delivered via an investigational eFlow ® Nebulizer System (PARI Pharma GmbH) specifically developed for inhalation of a large molecule. Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. More information can be found at www.savarapharma.com and LinkedIn.
*MOLBREEVI is the FDA and EMA conditionally accepted trade name for molgramostim inhalation solution. It is not approved in any indication. MOLBREEVI is a trademark of Savara Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Nvidia's (NVDA) Data Center Boom Continues — Analyst Lifts Price Target to $192
NVIDIA Corporation (NASDAQ:NVDA) is one of the . On July 23, Rothschild & Co Redburn's Timm Schulze‑Melander raised his price target on the stock to $192 from $173, maintaining a 'Buy' outlook. The firm said that earnings visibility is improving. Moreover, AI models' performance has improved roughly 5% per quarter since May 2023. This has, in turn, incited 'huge spending' on Nvidia data‑center compute. 'Nvidia is back to playing offense and recent sovereign investment deals improve earnings visibility. We raise our FY26-28 estimates between 1% and 5% and raise our price target to $192 from $178.' NVIDIA Corporation (NASDAQ:NVDA) specializes in AI-driven solutions, providing high-performance GPUs and platforms that power data centers, autonomous vehicles, robotics, and cloud services. While we acknowledge the potential of NVDA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.
Epoch Times
43 minutes ago
- Epoch Times
LIVE NOW: Trump Meets European Commission President in Scotland
LIVE NOW: Trump Meets European Commission President in Scotland President Donald Trump meets with President of the European Commission Ursula von der Leyen to discuss transatlantic trade relations at 11:30 a.m. ET on July 27.
Miami Herald
an hour ago
- Miami Herald
New to The Street Show #680 to Air Saturday, July 26 at 6:30 PM EST on Bloomberg TV
Featuring DataVault, NRX Pharmaceuticals, FLOKI, Interlink Labs, and Arrive AI Sponsored Programming by Arrive AI, MUSQ - The Music ETF, NRX Pharma, Commercialville TV, and The Sustainable Green Team NEW YORK CITY, NEW YORK / ACCESS Newswire / July 25, 2025 / New to The Street, a premier national business television program, will broadcast Episode #680 on Saturday, July 26 at 6:30 PM EST on Bloomberg TV as sponsored programming. This new episode features dynamic interviews and updates from five industry-disrupting companies: DataVault Holdings (Nasdaq:DVLT) - Revolutionizing secure data monetization using blockchain and AI Pharmaceuticals (Nasdaq:NRXP) - Advancing cutting-edge therapies in psychiatry and infectious - A leading crypto project merging meme power with real-world utility and DeFi Labs - Bridging biotechnology and artificial intelligence through advanced research and AI (Nasdaq:ARAI) - Redefining last-mile delivery with intelligent, contactless logistics powered by AI and automation. The program is proudly supported by its sponsoring partners:Arrive AI, MUSQ - The Music ETF, NRX Pharma, Commercialville TV, and The Sustainable Green Team - each playing a vital role in the innovation economy. About Us - New to The Street Since 2009, New to The Street has been a trusted financial media brand, producing and broadcasting content that drives awareness, credibility, and market visibility for companies across all sectors. With national broadcasts on Fox Business and Bloomberg Television, we have built the largest linear TV audience in the business and financial news sector. Our YouTube channel, @NewToTheStreetTV, leads the industry with over 3.1 million subscribers, offering expansive on-demand reach. This is reinforced by a social media following of over 511,000 across Facebook, LinkedIn, X (formerly Twitter), and Instagram. We enhance every campaign with iconic outdoor media - including digital billboards in Times Square, Nasdaq and Reuters towers, and bus shelters throughout New York's Financial District - delivering unmatched brand exposure and amplification. New to The Street is the only platform combining long-form television, sponsored and earned media, social engagement, and outdoor branding into one predictable and scalable media ecosystem. For Media Inquiries: Monica BrennanMedia Relations - New to The StreetMonica@ SOURCE: New To The Street
